4P4C | Human EphA3 Kinase domain in complex with quinoxaline derivatives | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Dong, J., Caflisch, A. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.60 | ||||||||||||
ligand | 25Q | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Pyrrolo[3,2-b]quinoxaline Derivatives as Types I and II Eph Tyrosine Kinase Inhibitors: Structure-Based Design, Synthesis, and in Vivo Validation., Unzue A, Dong J, Lafleur K, Zhao H, Frugier E, Caflisch A, Nevado C, J Med Chem. 2014 Jul 30. PMID:25076195 |
Data retrieval |
View 4P4C in 3D |
Visual 3D analysis of 4P4C |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4P4C |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |